Molly K. Webster

  • Citations Per Year
Learn More
The history of DNA profiling in the Home Office Forensic Science Service began with the introduction of multilocus probes into casework in 1986. The use of single-locus probes was introduced in 1990, supported by databases of three ethnic groups; interpretation is backed up using a Bayesian approach. Databases were compiled using an image analysis computing(More)
AIM To determine the potential for drug interactions involving cytochrome P450 (CYP) in patients receiving palliative day care. METHODS Drugs used by patients attending four specialist palliative day care centres were reviewed to identify combinations that could result in a pharmacokinetic interaction via any of the five main human forms of CYP. RESULTS(More)
“Here we are just playing Angry Birds,” says Wilson To. “How do we unlock [the] smartphone’s potential?” To is trying to do just that at Caradigm, a joint health technology venture of GE Healthcare and Microsoft Corporation. To is the lead researcher and codeveloper of Lifelens, a mobile phone– based diagnostic tool. Lifelens is still in its visionary(More)
The latest Ebola outbreak is the diagnostics grand challenge of the moment. Groups across the world are racing to build the “ideal test” that according to the WHO should work without laboratory infrastructure, take fewer than 3 steps, report results in under 30 min, and have minimum biosafety requirements (1 ). Leo Poon, head of Public Health Laboratory(More)
Many of the assays produced in the diagnostics field today take advantage of molecular labeling. Are you a coach who wants to know if your player is taking a performance-enhancing drug? A doctor interested in the disease status of your patient? Or, a TSA official wondering if there are explosives in a bag? Label it! But as diseases, drugs, and other threats(More)
Lyme disease is a worrisome condition for both patients and clinicians. Patients have questions about symptoms, diagnosis, and the meaning of chronic Lyme disease. In laboratories, Borrelia burgdorferi is hard to culture, limiting our understanding of disease progression postinfection as well as interfering with our diagnostic abilities. “Current tests for(More)